 Purification strategy for native Sigma GST protein from liver fluke  Separation of Mu and Sigma GST class proteins by isoelectric point difference  Proteomics validation of column chromatography purification
FhGSTS1 is yet to be tested for immune-modulation activities or for vaccine potential, primarily due to the technical difficulty in purifying FhGST-S1 away from the other more abundant GST members in F. hepatica cytosol. This paper reports a pipeline for the purification of native FhGSTS1 using a two-step process consisting of glutathione-agarose affinity and cationic exchange chromatography. The methodology allows for the isolation of purified and active FhGSTS1 or Sigma GSTs from other sources for analytical biochemical and immunological studies.
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Introduction
Fasciola hepatica, is a major parasite of livestock and humans in temperate regions throughout the world. Fascioliasis negatively impacts upon the welfare and production of domestic livestock, with infected animals exhibiting marked decreases in the yields of meat, milk and wool, reduced fertility and risk of sudden early death [1] . This loss of production is a threat to global food security, with an estimated annual cost of at least $3 billion [2] . In addition, F. hepatica is re-emerging as a global food borne disease of human populations, with up to 17 million people infected and a further 180 million at risk [3] .
Control of F. hepatica has been mainly achieved through the application of short-lived anthelmintic chemicals to treat both infected livestock and humans. The drug of choice for especially the acute disease is Triclabendazole (TCBZ); unique in its ability to target both pathogenic juvenile and adult F. hepatica [4] . However, the over reliance on TCBZ has driven the emergence and spread of drug resistant liver fluke isolates, further threatening problematic disease control [5] . Moreover, the mechanisms underpinning TCBZ resistance are currently unknown, hindering the detection of resistance at an early stage.
The declining global efficacy of TCBZ is unfortunately coupled with climate change increasing disease incidence and range [6] . In the continued absence of a TCBZ replacement there is renewed drive to develop a commercially sustainable liver fluke vaccine. Many vaccine targets for F. hepatica have been identified and experimentally tested, most show too low protection rates for commercial development and some fail when vaccine trials are repeated [7] . A panel of the most promising liver fluke vaccine candidates include members of the soluble glutathione transferase superfamily, such as recently discovered Sigma class glutathione transferase (FhGSTS1), a Hematopoietic Prostaglandin D synthase [8, 9, 10, 11] .
FhGSTS1 has been shown to be secreted from liver fluke via extracellular vesicles, exhibit prostaglandin synthase activity, suppress a Th17 response in host dendritic cells via TLR-4 dependent binding and stimulate increased prostaglandin release from host cells [12, 13, 
. These abilities suggest that FhGSTS1 has keys establishment roles within the host and importantly the location of this protein, in the tegument, fluke secretions [15] and extracellular vesicles [12] , makes it susceptible as part of a blocking antibody vaccine strategy and/or new target for chemical anthelmintics. However, these above immunological and biochemical assays have only been performed using a recombinant form of this protein (rFhGSTS1) [10, 13] .
Unfortunately, vaccine trials with rFhGSTS1 did not significantly reduce the fluke challenge burden of infected goats, despite a reduction in lesions and necrotic tracts in the host liver tissue. Interestingly, previous experimental vaccinations with a native FhGST (nFhGST) isoenzyme mix likely incorporated FhGSTS1 protein and provided almost a 70% reduction in worm burden in a cattle trial [16] . Furthermore, it has been shown recently that the nFhGSTS1 likely undergoes O-linked glycosylation [17] and this may be an important component of a protective vaccine formulation that has not been tested by current recombinant forms.
To date, native GST studies are hampered in parasitic worms by lack of methodology to separate Sigma GST protein from other more abundant soluble GST classes such as Mu.
Thus, the aim of this investigation was to isolate nFhGSTS1 from somatic extracts of adult F.
hepatica through a two-step purification pipeline utilising GSH-agarose affinity chromatography, followed by cationic exchange chromatography in order to exploit the relatively high pI of FhGSTS1. Finally, nFhGSTS1 enrichment and purification were confirmed using 2DE, western blotting and tandem mass spectrometry.
Materials and Methods

1 Protein sample preparation
Adult liver fluke were obtained from freshly condemned sheep livers at a local abattoir in West Wales and were extensively washed in PBS then stored at -80°C until required.
Somatic protein was extracted on ice from 5 g of pooled adult F. hepatica in 1:10 (v/v) homogenisation buffer (10 mM sodium phosphate, 1 % v/v Triton X-100, pH 7.4, 1 tablet of cOmplete™, Mini, EDTA-free Protease Inhibitor Cocktail (Sigma-Aldrich)) and centrifuged at 21,000 x g for 30 min at 4°C, with the supernatant containing soluble proteins, including GST classes, collected, sonicated for three 15 second pulses and termed the somatic extract.
Protein Concentration and GST Enzymatic Assay
Protein concentration was estimated using the method of Bradford [21] . The CDNB (1-Chloro-2,4-dinitrobenzene) glutathione conjugation model substrate assay was used to measure GST activity [22] . The assay was completed in a 1 ml volume, with a final concentration of 100 mM potassium phosphate buffer (pH 6.5), 1 mM reduced glutathione, 1 mM CDNB and absorbance changed measured at 340 nm for 3 min at 20 °C. The model substrate ethacrynic acid was also tested according to the method previously described [13] .
2.3 Glutathione-Agarose Affinity Chromatography A 1 ml volume matrix of GSH-agarose was prepared in column format according to the manufactures instructions (Sigma Ltd). In brief, the matrix was equilibrated with 20 column volumes (CVs) of 10 mM sodium phosphate buffer pH 7.4 containing 150 mM NaCl at a flow rate of 1.5 ml/min at room temperature. Somatic extract was passed through the column under gravity flow a total of six times. The column was washed with 20 CVs of the previously described equilibration buffer. The elution of bound protein was achieved by passing 5 CVs of elution buffer (50 mM Tris-HCl) pH 8.0 containing 5 mM GSH, at a flow rate of 1.0ml/min at room temperature. The collected eluent was then concentrated using 10 kDa MWCO centrifuge filter units (Amicon) and exchanged to 20 mM sodium phosphate buffer, pH 6.8.
Cationic Exchange Chromatography
Pre-packed 1 ml, HiTrap, fast-flow, carboxy-methyl (CM) Sepharose columns from G. E.
Healthcare Ltd were linked to an automated ÄKTA prime plus system (G. E. Healthcare). All buffers and solutions for CM chromatography were passed through 0.45 µm cellulose filters.
Initially, the system was washed and primed with buffer A (20 mM sodium phosphate buffer, pH 6.8) with the column installed with a system flow rate of 1.0 mL/min. Equilibration of the column was achieved by washing through 20 CVs of buffer A. The GSH-affinity purified sample was loaded into the AKTA system at 4°C using a 500 µl sample loop and passed through the column at the optimal flow rate of 1.0 ml/min. The column was washed again with 20 CVs of buffer A. Adsorbed protein was eluted from the column using a single step increase in NaCl concentration achieved by passing 100% buffer B (20 mM sodium phosphate, 1.0 M NaCl, pH 6.8) through the column. PrimeView version 1.0 software (G. E.
Healthcare) was used to monitor protein flow through, at 220 nm. Protein peaks in the UV chromatograph were collected in 1 ml fractions and protein containing fractions pooled for subsequent analyses.
1-Dimensional SDS-PAGE
Protein profiles were resolved by 1D SDS-PAGE. Samples were denatured in Laemmli sample buffer (BioRad) and heated to 95°C for 15 min and separated on a 12.5% acrylamide gel using a mini-Protean kit (Biorad) equilibrated with TGS gel running buffer (25 mM Tris, 192 mM glycine, 0.1 % w/v SDS, pH 8.6). The protein separation was completed at 70 V for 30 min and then 150 V for 90 min. Proteins were visualised using colloidal Coomassie staining [22] and imaged using a GS-800 densitometer (Biorad) and analysed with QuantityOne software (Biorad).
2-Dimensional electrophoresis
Isoelectric focusing was carried out using 7 cm linear pH 3-10 immobilized Readystrip™ IPG strips (BioRad). In brief, the IPG strips were rehydrated for 16 hrs with a solution comprising of the protein sample and buffer Z (8 M urea, 2 % w/v CHAPS, 33 mM DTT, 0.5 % v/v ampholytes pH 3-10). The hydrated strips were focused using a Protean Kit (Biorad) for 10,000 VH at 20°C. After focusing the IPG strips were placed in equilibration buffer (50 mM Tris-HCl, 6 M urea, 30 % v/v glycerol, 2 % w/v SDS, pH 6.8) containing 10 mg/ml DTT, for 15 min at room temperature. A second equilibration step followed in which the IPG strip was placed in same equilibration buffer containing 25 mg/ml IAA. After equilibration the IPG was placed on to a 12.5 % acrylamide gel and fixed in position with molten agarose. Separation by molecular weight was performed according to the conditions for 1D SDS-PAGE.
Western Blotting
Western blotting was performed using a mini blot kit (Biorad), with the protein transferred from 1D SDS-PAGE 12.5 % acrylamide gels to nitrocellulose membrane. Prior to blotting, the gels and membranes were soaked in western blot equilibration buffer (25 The data was filtered by molecular feature and exported as a MASCOT generic file (MGF).
Using a local 'in house' MASCOT database (www.matrixscience.com) of the F. hepatica genome, the acquired MGF files submitted for a MS/MS ion search, using parameters previously described [24] . Homology was determined to be significant (p<0. (Table 1) .
Cationic exchange (CM-Sepharose) was used to isolate basic pI nFhGSTS1 away from other acidic and near neutral pI GSH-agarose binding GSTs. This second stage required optimisation of the initial pH conditions i.e. adsorption of nFhGSTS1 and the removal of the non-interacting Mu class FhGSTs. nFhGSTS1 was predicted to have a pI of 8.86 using the compute pI/MW tool (http://www.expasy.org/proteomics) and this was similar to the published experimental value of 8.56 [11] . Thus, purifications were carried out with various equilibration buffer pH ranges and the optimal conditions determined to be at pH 6.8. Under the optimised conditions, a single elution peak was observed in the UV chromatogram ( Figure 1A ) when the column was washed with 100% buffer B. Due to the low concentration of eluted protein, fractions 44 and 45 were pooled and determined to have a specific activity of 1471 ± 345.5 nmol.min -1 .mg -1 protein ( Table 1) . The CM-Sepharose purified sample Table 1 . Importantly, no other protein spots were detected by the colloidal Coomassie stain showing that nFhGSTS1 is the only protein present in the sample and it remains stable throughout this method of purification (Figure 3) . Furthermore, nFhGSTS1 retained activity towards CDNB (Table 1 ) and also exhibited activity towards the model substrate ethacrynic acid with an average specific activity of 1482.25 nmol.min -1 .mg -1 protein (n=2), this was higher than the specific activity measured for rFhGSTS1 [13] . 
Discussion
This investigation has delivered a new pipeline for the production of purified nFhGSTS1 from somatic protein extracts of adult F. hepatica tissue. Importantly, the end-product of this twostep process was a structurally stable and enzymatically active native protein, supporting robust immunological and biochemical studies.
Interestingly, nFhGSTS1 exhibited greater ethacrynic acid glutathione conjugation activity and less CDNB glutathione conjugation activity than rFhGSTS1 [13] . The differences in substrate activities between the recombinant and the native form of FhGSTS1 further highlight the potential limitation of bacterial host protein production technology and lack of eukaryotic post-translational modifications may have had consequence on the previous rFhGSTS1 vaccine studies. Thus, native proteins may be required to fully understand hostparasite interactions in order to realise liver fluke protective vaccines [28] . However, with respect to future research, native parasitic worm protein isolation strategies is challenging as it requires removing parasites from vertebrates with often relatively low yield of final purified antigen. In this study each batch of purification round required 5g of F. hepatica tissue to yield 50 µg of purified target protein to study.
Previous proteomic work identified Sigma GST protein in more near neutral protein spots (pI 7.1) along with Mu class GSTs in F. hepatica extracts [11] . This finding is further supported in this biochemical study as Sigma GST was also detected in the CM-Sepharose unbound fractions, suggesting that a more acidic modified form of nFhGSTS1 or an additional Sigma class GST may also be expressed. Native GSTs consist of two subunits, either as homodimers or heterodimers [22] . Thus, the formation of native heterodimeric FhGSTs with extended functions in liver fluke cannot be also be ruled out, especially as heterodimeric GSTs have recently been described in another parasitic flatworm, the cestode Echinococcus granulosus [27] .
In conclusion, our new methodology allows for the isolation of purified and active FhGSTS1 or basic pI Sigma GSTs other sources for analytical biochemical and immunological studies, such as vaccination trials in rodent models. We envisage that the column bed volumes can be increased for more preparative studies. A C C E P T E D M A N U S C R I P T
